CSI Market
Sign In | Register

Provectus Biopharmaceuticals Inc (PVCT) Annual Balance Sheets

Annual · GAAP · USD millions
Access PVCT quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Provectus Biopharmaceuticals Inc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.25
Cash & Short-term Investments0.00
Accounts receivable0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.32
Total Current Assets0.57
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.13
Total Assets0.70
Liabilities
Accounts Payable, Current AC0.72
Accrued Liabilities, Current3.16
Short-term Debt0.87
Other Liabilities, Current2.15
Deferred Revenue, Current DE0.00
Total Current Liabilities6.90
Long-term debt0.02
Total Long-term Debt0.02
Other liabilities, Noncurrent0.08
Total Liabilities7.00
Stockholders' Equity
Common Stock Value0.42
Additional Paid In Capital Common Stock256.18
Retained Earnings / Accumulated Deficit-262.85
Other Equity-0.05
Common Stockholder's Equity-6.30
Preferred Stockholder's Equity0.00
Non-controlling interests & other0.00
Total Stockholder's Equity-6.30
Liabilities & Stockholder's Equity0.70
4 historic quarters locked

Sign in to unlock the full Provectus Biopharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Provectus Biopharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 25, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-012726

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License